ImmuCell Corp: reports Q3 2026 product sales up 46%

What happened

• On Oct 12, 2026 ImmuCell Corporation announced a 46% increase in product sales in quarter 3 of 2026 as compared to quarter 3 of 2025, based on preliminary, unaudited sales results for the quarter ended Sep 30, 2026. The company issued a press release in connection with the announcement.

Key details

• 46% increase in product sales in quarter 3 of 2026 versus quarter 3 of 2025.
• Announcement made by press release dated Oct 12, 2026; results cover the quarter ended Sep 30, 2026.
• Results described as preliminary and unaudited.
• The filing states the information shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference in other filings.

Why it may matter

• This was reported under Item 2.02 (results of operations and financial condition), which covers reported operating results and financial condition for the period.
  A filing does not show why the insider traded or why the company acted.